Z, C., CR, B., PW, T., BA, S., JP, A., CA, T., . . . MW, C. (2021). Carbapenem Use Is Driving the Evolution of Imipenemase 1 Variants. Antimicrobial agents and chemotherapy, 65(4), . https://doi.org/10.1128/AAC.01714-20
Chicago Style (17th ed.) CitationZ, Cheng, et al. "Carbapenem Use Is Driving the Evolution of Imipenemase 1 Variants." Antimicrobial Agents and Chemotherapy 65, no. 4 (2021). https://doi.org/10.1128/AAC.01714-20.
MLA (9th ed.) CitationZ, Cheng, et al. "Carbapenem Use Is Driving the Evolution of Imipenemase 1 Variants." Antimicrobial Agents and Chemotherapy, vol. 65, no. 4, 2021, https://doi.org/10.1128/AAC.01714-20.
Warning: These citations may not always be 100% accurate.